Updates on medical advances, environmental initiatives, and emerging technologies.
Technion scientists have developed a pioneering technology that uses harmless live bacteria to produce therapeutic drugs directly inside the body. Delivered via a painless microneedle patch, the bacteria act as tiny drug factories, improving bioavailability and potentially reducing treatment costs and repeated dosing.
Technion researchers have developed SafeWax, a bio-inspired spray coating that forms a thin, biodegradable, water-repellent layer on crops. This innovative technology can reduce the need for chemical pesticides by more than 50%, protect plants from disease and heat stress, and help lower agriculture’s environmental footprint.
New Technion research will advance a solution to strokes caused by a blockage of a major brain artery — known as a large vessel occlusion (LVO) — which are medical emergencies. If treatment is delayed, the consequences can be devastating: severe brain damage, disability, or death.
Technion Researchers reveal complex interactions between heart disease and cancer, in the hope that their findings will lead to improved treatment for both conditions.
According to researchers at the Technion – Israel Institute of Technology, the future of energy lies in technological breakthroughs in porous materials, whose influence extends across diverse fields – from computing systems to biomedical engineering. Published in Science, their findings present a long-term roadmap for the evolution of the energy sector.
Technion scientists unveil a fast-acting bio-glue that bonds wet tissues in seconds—reducing bleeding, infections and the need for stitches.
The Technion has been awarded 5.75 million NIS in Mavri grants to develop engineered tissues aimed at heart rehabilitation and improving treatments for juvenile diabetes.
In a groundbreaking study, Technion researchers discovered that Bacillus bacteria form protective biofilms within desert dust particles, allowing them to endure extreme conditions during transport from the Sahara and Egypt to Israel. This finding sheds light on the resilience of microbial life and its potential impact on global ecosystems.
Technion researchers unveil a painless, needle-free system for glucose monitoring and smart insulin delivery—bringing comfort, accuracy, and ease to diabetes care.
Technion scientists reveal that soft drinks can disrupt gut microbiome signaling, potentially undermining immune system communication and overall health.
A Technion-led study shows significant gender differences in the digestion of dairy and plant-based milks, underscoring the need for personalised food engineering.
Technion scientists introduce a breakthrough in decoupled water electrolysis, paving the way for efficient, industrial-scale green hydrogen production.
